News Releases Investor Alerts Year All Years 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Category All Categories 4Web Medical Acerus Pharmaceuticals Aimmune Therapeutics Biolase DxTerity Diagnostics Enteris Biopharma Eton Pharmaceuticals Keystone Dental Misonix/Solsys Medical SWK Holdings Tenex Health Veru Keywords GO Advanced Search NOV 2021 24 SWK Holdings Confirms Receipt of Non-Binding Proposal from Carlson Capital L.P. Announces Formation of Special Committee SWK Holdings Corporation (Nasdaq: SWKH) (the "Company" or "SWK") confirmed that on November 23, 2021, it received a non-binding proposal from funds managed by Carlson Capital, L.P. ("Carlson") to... NOV 2021 17 Enteris BioPharma Publishes Article Examining the Growing Utilization of the 505(b)(2) Regulatory Pathway in Drug Development Paper Discusses the 505(b)(2) Pathway as a Vehicle for Innovation and Product Differentiation Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation... NOV 2021 12 SWK Holdings Corporation Announces Financial Results for Third Quarter 2021 Conference Call and Live Audio Webcast Scheduled for Monday, November 15, 2021 at 10:00 a.m. ET Corporate Updates Conclusion of strategic review process with SWK to focus on specialty finance receivables business SWK evaluating ongoing dividend and additional leverage Third Quarter 2021... NOV 2021 02 Enteris BioPharma Publishes White Paper on Best Practices in the Manufacturing of HPAPI Solid Oral Drug Products Paper Examines the Opportunities and Challenges in Working with High Potency APIs Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation... NOV 2021 01 SWK Holdings Announces Strategic Plan to Focus on Core Specialty Finance Business Commitment to focus on and grow SWK's core specialty finance business going forward SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided an... Show 5 per page «123456789…19» © Copyright 2021. All Rights Reserved. SWK Holdings Corporation 14755 Preston Road, Suite 105 Dallas, TX 75254 Phone: 972.687.7250 Fax: 972.687.7255 For Investors: investorrelations@swkhold.com For Capital Alternatives: inquiries@swkhold.com For Career Opportunities: recruiting@swkhold.com